辉文生物 (832402.OC)

+ 收藏

财务摘要(报告期)(辉文生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
每股指标:
 每股收益 - 基本(元) -0.010.09-0.48-0.44
 每股收益 - 稀释(元) -0.010.09-0.48-0.44
 每股收益 - 期末股本摊薄(元) -0.370.010.09-0.48-0.44
 每股净资产BPS(元) 7.277.637.707.617.64
 每股经营活动产生的现金流量净额(元) -0.220.25-0.270.100.02
 每股营业收入(元) 1.675.242.023.371.21
关键比率:
 净资产收益率 - 摊薄(%) -5.090.181.12-6.25-5.81
 净资产收益率 - 加权(%) -0.181.12-6.07-5.64
 净资产收益率 - 平均(%) -4.970.181.12-6.06-5.64
 净资产收益率 - 扣除(%) --2.610.40-8.17-6.25
 总资产净利率 - 平均(%) -3.300.120.73-4.02-3.91
 总资产报酬率ROA(%) -2.72-0.061.37-3.79-3.32
 投入资本回报率ROIC(%) -2.900.431.45-3.02-3.55
 销售毛利率(%) 44.4339.0845.0745.7746.37
 销售净利率(%) -22.210.264.25-14.10-36.68
 资产负债率(%) 34.4033.0133.9135.1529.16
 资产周转率(倍) 0.150.450.170.290.11
 销售商品提供劳务收到的现金/营业收入(%) 139.9294.8596.64107.61123.54
 营业利润同比增长率(%) -525.7393.08118.96-3,506.85-299.89
 营业收入同比增长率(%) -17.5355.3667.34-5.14-13.46
 利润总额同比增长率(%) -526.8793.29119.60-305,623.07-299.86
 归属母公司股东的净利润同比增长率(%) -531.09102.89119.38-2,541.41-292.26
 扣非后归属母公司股东的净利润同比增长率(%) -67.95106.40-802.03-237.11
 总资产同比增长率(%) -4.81-2.918.04-1.40-7.15
 总负债同比增长率(%) -3.42-8.8325.667.91-13.89
 净资产同比增长率(%) -5.520.300.80-5.81-4.05
利润表摘要:
 营业总收入(元) 44,660,196.86140,311,287.0354,152,965.6590,316,513.9032,360,476.11
 营业总成本(元) 56,096,030.31141,374,015.0054,104,393.01104,151,765.4044,226,279.58
 营业收入(元) 44,660,196.86140,311,287.0354,152,965.6590,316,513.9032,360,476.11
 营业利润(元) -9,577,727.26-1,042,512.132,249,721.54-15,062,305.10-11,864,822.22
 利润总额(元) -9,923,941.77-1,064,385.622,324,819.48-15,855,042.94-11,864,122.01
 净利润(元) -9,917,521.28368,028.842,300,588.86-12,733,978.98-11,868,736.72
 归属母公司股东的净利润(元) -9,917,521.28368,028.842,300,588.86-12,733,978.98-11,868,736.72
 非经常性损益(元) -5,704,757.801,482,963.273,913,133.62901,618.96
 归属母公司股东的净利润扣除非经常性损益(元) --5,336,728.96817,625.59-16,647,112.60-12,770,355.68
资产负债表摘要:
 流动资产(元) 63,956,621.4367,221,401.6477,729,363.1573,523,780.8260,442,645.11
 固定资产(元) 199,047,033.16203,546,578.32199,001,301.96206,394,357.21202,198,154.59
 长期股权投资(元) 2,682,441.192,679,645.362,099,886.872,630,398.81386,923.87
 资产总计(元) 296,814,021.69305,066,248.14311,814,385.02314,200,152.84288,596,891.18
 流动负债(元) 74,516,102.34100,684,851.1390,679,430.1790,409,214.8754,125,916.79
 非流动负债(元) 27,594,876.215,351.6215,052,124.7720,029,598.2830,017,175.24
 负债合计(元) 102,110,978.55100,690,202.75105,731,554.94110,438,813.1584,143,092.03
 股东权益(元) 194,703,043.14204,376,045.39206,082,830.08203,761,339.69204,453,799.15
 归属母公司股东的权益(元) 194,703,043.14204,376,045.39206,082,830.08203,761,339.69204,453,799.15
 资本公积(元) 105,680,261.12105,488,334.79105,187,523.44105,187,523.44105,014,740.64
 盈余公积(元) 9,069,658.709,069,658.708,685,681.418,685,681.418,685,681.41
 未分配利润(元) 53,184,665.1163,102,186.3965,418,723.7063,118,134.8463,983,377.10
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 62,487,688.96133,086,640.9652,332,180.2197,185,420.3739,976,786.80
 经营活动产生的现金净流量(元) -5,957,272.666,727,912.74-7,132,851.212,560,556.59485,947.26
 购建固定无形长期资产支付的现金(元) 5,485,558.8312,718,926.903,881,924.3018,631,858.689,456,721.01
 投资支付的现金(元) -600,000.00600,000.004,100,000.00-
 投资活动产生的现金净流量(元) -5,485,558.83-11,960,322.19-4,648,434.42-21,270,480.84-9,301,891.01
 吸收投资收到的现金(元) --5,000,000.00--
 取得借款收到的现金(元) 52,080,000.0065,360,000.0012,360,000.0064,500,000.0014,000,000.00
 筹资活动产生的现金净流量(元) 7,326,133.64-13,357,294.53663,453.284,883,439.52-12,646,196.80
 现金及现金等价物净增加(元) -4,142,575.47-19,049,644.79-11,655,863.04-13,379,272.35-22,081,040.75
 期末现金及现金等价物余额(元) 3,711,809.807,854,189.1515,910,318.6126,903,833.9418,202,065.54
 折旧与摊销(元) --5,532,708.6113,481,021.038,115,711.37
公告日期 2024-08-152024-04-182023-08-182023-04-202022-08-19
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院